**Core Concept**
The question is testing the student's knowledge of orally acting direct thrombin inhibitors, which are a class of anticoagulant medications that prevent blood clot formation by directly inhibiting the enzyme thrombin. These medications are used to prevent and treat thrombotic disorders.

**Why the Correct Answer is Right**
Dabigatran is an orally acting direct thrombin inhibitor that works by selectively binding to and inhibiting thrombin, the final common pathway in the coagulation cascade. This results in a rapid and sustained anticoagulant effect. Dabigatran has a favorable pharmacokinetic profile, with a predictable dose-response relationship and minimal drug interactions.

**Why Each Wrong Option is Incorrect**
**Option A:** Warfarin is a vitamin K antagonist that inhibits the synthesis of vitamin K-dependent clotting factors, but it is not a direct thrombin inhibitor.
**Option B:** Fondaparinux is a synthetic pentasaccharide that inhibits factor Xa, but it does not directly inhibit thrombin.
**Option C:** Apixaban is a factor Xa inhibitor that prevents the coagulation cascade from proceeding, but it does not directly inhibit thrombin.

**Clinical Pearl / High-Yield Fact**
Dabigatran has a narrow therapeutic index, and its anticoagulant effect can be reversed with idarucizumab, a specific antidote.

**Correct Answer:** D. Dabigatran.